Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
J. Clin. Invest. Ahmed Boucharaba, et al. 114:1714 doi:10.1172/JCI22123 [Go to this article.]

Table 1
Quantification of osteolytic lesions and skeletal tumor burden in untreated and doxycycline-treated animals bearing parental MDA-BO2 breast cancer cells or clone no. 3 and clone no. 79 cells overexpressing HA-LPA₁